Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Tomography (Ann Arbor, Mich.)
|
March 26, 2025
Delta Radiomics and Tumor Size: A New Predictive Radiomics Model for Chemotherapy Response in Liver Metastases from Breast and Colorectal Cancer
Nicolò Gennaro, Moataz Soliman, Amir A Borhani, et al.
Blood Neoplasia
|
July 30, 2025
Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408
Frederique St-Pierre, Stephen M Broski, Zequn Sun, et al.
Cancers
|
May 27, 2026
A Predictive MRI Radiomics Model for Histologic Differentiation in Soft Tissue Sarcomas
Laetitia Perronne, Nicolò Gennaro, Zuzanna Kobus, et al.
JAMA Oncology
|
March 17, 2023
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial
Locke J Bryan, Carla Casulo, Pamela B Allen, et al.
Journal of Clinical Medicine
|
September 27, 2025
Intracranial Metastases from Uterine Leiomyosarcoma: A Systematic Review and Case Illustration
Ahmad Pour-Rashidi, Sara Zandpazandi, Laetitia Perronne, et al.
Blood
|
September 29, 2020
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma
Pamela B Allen, Hatice Savas, Andrew M Evens, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 10, 2025
Utility of <sup>18</sup>F-DCFPyL PET for local staging for high or very high risk prostate cancer for patients undergoing radical prostatectomy
Eric V Li, Edward M Schaeffer, Sai Kaushik Shankar Ramesh Kumar, et al.
Cancers
|
March 13, 2025
Paradoxical Response to Neoadjuvant Therapy in Undifferentiated Pleomorphic Sarcoma: Increased Tumor Size on MRI Associated with Favorable Pathology
Mariam H Goreish, Nicolò Gennaro, Laetitia Perronne, et al.
Blood Advances
|
September 9, 2022
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma
Pamela B Allen, Xinyan Lu, Qing Chen, et al.
Skeletal Radiology
|
March 3, 2026
Performance of deep learning-based segmentation of soft tissue sarcoma by MRI sequence, tumor type and location
Linkai Peng, Laetitia Perronne, Nicolò Gennaro, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Tomography (Ann Arbor, Mich.)
|
March 26, 2025
Delta Radiomics and Tumor Size: A New Predictive Radiomics Model for Chemotherapy Response in Liver Metastases from Breast and Colorectal Cancer
Nicolò Gennaro, Moataz Soliman, Amir A Borhani, et al.
Blood Neoplasia
|
July 30, 2025
Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408
Frederique St-Pierre, Stephen M Broski, Zequn Sun, et al.
Cancers
|
May 27, 2026
A Predictive MRI Radiomics Model for Histologic Differentiation in Soft Tissue Sarcomas
Laetitia Perronne, Nicolò Gennaro, Zuzanna Kobus, et al.
JAMA Oncology
|
March 17, 2023
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial
Locke J Bryan, Carla Casulo, Pamela B Allen, et al.
Journal of Clinical Medicine
|
September 27, 2025
Intracranial Metastases from Uterine Leiomyosarcoma: A Systematic Review and Case Illustration
Ahmad Pour-Rashidi, Sara Zandpazandi, Laetitia Perronne, et al.
Blood
|
September 29, 2020
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma
Pamela B Allen, Hatice Savas, Andrew M Evens, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 10, 2025
Utility of <sup>18</sup>F-DCFPyL PET for local staging for high or very high risk prostate cancer for patients undergoing radical prostatectomy
Eric V Li, Edward M Schaeffer, Sai Kaushik Shankar Ramesh Kumar, et al.
Cancers
|
March 13, 2025
Paradoxical Response to Neoadjuvant Therapy in Undifferentiated Pleomorphic Sarcoma: Increased Tumor Size on MRI Associated with Favorable Pathology
Mariam H Goreish, Nicolò Gennaro, Laetitia Perronne, et al.
Blood Advances
|
September 9, 2022
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma
Pamela B Allen, Xinyan Lu, Qing Chen, et al.
Skeletal Radiology
|
March 3, 2026
Performance of deep learning-based segmentation of soft tissue sarcoma by MRI sequence, tumor type and location
Linkai Peng, Laetitia Perronne, Nicolò Gennaro, et al.
Page
of 5